Avalo Therapeutics Inc (AVTX) — Cash Flow Reinvestment Rate
Avalo Therapeutics Inc (AVTX) has a Cash Flow Reinvestment Rate of 0.01x as of September 2022, reinvesting $78.00K (capex $39.00K plus investments $-39.00K) from operating cash flow of $5.73 Million. Explore AVTX capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Avalo Therapeutics Inc Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Avalo Therapeutics Inc across 1 annual periods. Also explore Avalo Therapeutics Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Avalo Therapeutics Inc (2017–2017)
Year-by-year capital reinvestment analysis for Avalo Therapeutics Inc. For live market cap and broader valuation context, see Avalo Therapeutics Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 1.03x | $12.86 Million | $12.52 Million | $23.32K | — |